Surender Kharbanda

This inventor holds 18 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Dana-Farber-Cancer Institute Inc., Genus Oncology, LLC, Genzyme Corporation. Active years: 2005-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Surender Kharbanda. Retrieved from https://idiyas.com/inventor/surender-kharbanda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 10)

% Patents Active = 83.3

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 12)

Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 12(Granted Patents)

Company Filing History:

15 out of 1,268

Dana-Farber-Cancer Institute Inc.

Hillstream Biopharma, Inc.

patents

5. 1 out of 1

Ilwz Ilex Products, Inc.

patent

6. 1 out of 1

Xyone Therapeutics Inc.

patent

where one patent can have more than one assignee

Years Active: 2005-2025

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12466895 - ANTIBODIES AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ECD) (2025-11-11),

2. 11484507 - Polymeric nanoparticles providing nucleic acids encoding TNF-α (2022-11-01),

3. 11136410 - Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD) (2021-10-05),

4. 10617773 - Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD) (2020-04-14),

5. 10059775 - Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD) (2018-08-28),

6. 9789156 - Combination anti-human epidermal growth factor receptor 2 (anti-HER2) cancer therapy using mucin 1 (MUC1) peptides and hemotherapeutics (2017-10-17),

7. 9663562 - Compositions and methods for treating cancer (2017-05-30),

8. 9572855 - Combination anti-estrogen receptor cancer therapy using MUC1 peptides and chemotherapeutics (2017-02-21),

9. 9546201 - MUC-1 cytoplasmic domain peptides as inhibitors of cancer (2017-01-17),

10. 9096687 - Inhibition of inflammation using antagonists of MUC1 (2015-08-04),

11. 9044421 - Treating MUC1-expressing cancers with combination therapies (2015-06-02),

12. 8957185 - MUC-1 cytoplasmic domain peptides as inhibitors of cancer (2015-02-17),

13. 8952054 - Small molecule inhibitors of MUC1 and methods of identifying the same (2015-02-10),

14. 8685928 - Antagonists of MUC1 (2014-04-01),

15. 8614186 - Inhibition of inflammation using antagonists of MUC1 (2013-12-24),

Title: The Innovative Journey of Surender Kharbanda

Introduction: Surender Kharbanda, a talented inventor based in Natick, MA (US), has made significant contributions to the field of innovations with his creative mindset and dedication to problem-solving.

Latest Patents: Surender Kharbanda holds several patents in various technological domains, showcasing his versatility and expertise in inventing cutting-edge solutions to complex challenges.

Career Highlights: Throughout his career, Surender Kharbanda has demonstrated a remarkable ability to translate ideas into tangible inventions that have the potential to revolutionize industries. His innovative spirit and passion for creating have led to the development of groundbreaking technologies.

Collaborations: Surender Kharbanda has collaborated with leading research institutions, universities, and companies to further his inventions and bring them to the market. His partnerships have been instrumental in advancing his innovative concepts and turning them into reality.

Conclusion: Surender Kharbanda's journey as an inventor is a testament to his ingenuity and commitment to driving progress through innovation. His work continues to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.